• Skip to primary navigation
  • Skip to main content
  • Skip to footer
PPI Logo
address
  • Home
  • About
    • Introduction
    • The Strength of PPI HC
    • Our Mission
    • Global Reach
    • Customers
    • Team
    • Gallery
  • Services
    • Landscape Assessments
    • Market Access Strategy
    • Research and Insights
    • Pricing Strategy
    • Reimbursement Strategy
    • Health Technology Assessment dossiers
    • Health Economics
    • Orphan & Rare Diseases
  • Communications
    • Case Studies
    • Publications
    • Conferences
  • Contact
  • Home
  • About
    • Introduction
    • The Strength of PPI HC
    • Our Mission
    • Global Reach
    • Customers
    • Team
    • Gallery
  • Services
    • Landscape Assessments
    • Market Access Strategy
    • Research and Insights
    • Pricing Strategy
    • Reimbursement Strategy
    • Health Technology Assessment dossiers
    • Health Economics
    • Orphan & Rare Diseases
  • Communications
    • Case Studies
    • Publications
    • Conferences
  • Contact

Case Studies

  • Home>
  • Case Studies>
Pricing, Early Access Strategy

Pricing, Early Access Strategy and Launch planning

Objectives: To assess opportunities for pre-approval use (PAU/early access) and pricing Therapy … [Read More...] about Pricing, Early Access Strategy and Launch planning

Value and Access Strategy

Value and Access Strategy

Objectives: To advise on such as clinical programme, reimbursement needs, market access, … [Read More...] about Value and Access Strategy

Pricing, Reimbursement and Launch Planning

Pricing, Reimbursement and Launch Planning Strategy

Objectives: To develop pricing and reimbursement (P&R) strategy, assess pre-approval use … [Read More...] about Pricing, Reimbursement and Launch Planning Strategy

Pricing and Reimbursement

P&R Due Diligence Assessment for 2 agents

Objectives: To assess the prospective pricing and reimbursement (P&R) environment for 2 novel … [Read More...] about P&R Due Diligence Assessment for 2 agents

COPD Payer research

COPD Payer research

Objectives: Payer research to assess unmet needs in COPD, perceptions of current therapeutic … [Read More...] about COPD Payer research

International Reimbursement planning

International Reimbursement planning

Objectives: To establish data needs and activities required to achieve reimbursement and market … [Read More...] about International Reimbursement planning

European Pricing and Reimbursement planning

European P&R planning

Objectives: To advise on such as clinical programme, reimbursement needs, market access, … [Read More...] about European P&R planning

Case Studies

  • Pricing, Early Access Strategy and Launch planning
  • Value and Access Strategy
  • Pricing, Reimbursement and Launch Planning Strategy
  • P&R Due Diligence Assessment for 2 agents
  • COPD Payer research
  • International Reimbursement planning
  • European P&R planning

TESTIMONIALS

“With their depth of market access experience across the EU, Adam Barak and his team at PPi Healthcare are well-positioned to provide timely, insightful guidance on pricing and reimbursement. ProMetic’s global strategic launch plans involving ultra-orphan therapies, have been greatly enhanced by our collaboration with PPi.”

Kristine Dorward, Director, Marketing & Business Development, ProMetic Life Sciences Inc.

“I want to let you know that the feedback from my colleagues after your presentation was that they are impressed by the amount of information that you have gathered within the research within such a short period.”

Ramona Schmid, Global Market Access, Pricing and Reimbursement Manager, HRA Pharma

“I have worked with PPi on several projects and I will work with them again. The first project was a European pricing study for an orphan product. Having already completed one study with a competitor, I found the PPi team to be particularly insightful, having taken the time to completely understand this complex project.”

Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals

“Recently I completed an assessment to inform the collection of pharmacoeconomic data in a clinical study in the US and Europe. The team again were very insightful and we had unexpected value-added when we found a member of the PPi had been involved in the pricing and reimbursement activities relating to one of our comparables. Great team, great results!”

Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals

PPI Logo

Adding global value through local expertise and insight

Adding global value through local expertise and insight

PPi Healthcare Consulting Ltd
The White House
Main Road, Dibden
Hampshire
SO45 5TB, UK

Further information:
E: info@ppi.consulting
T: +44 (0)2380 847891

Privacy Policy

© copyright 2020
PPi Healthcare Consulting Ltd
All rights reserved

This website uses cookies to improve your experience. To view our privacy policy click here. To change your cookie preferences:Cookie settingsor ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.